Cargando…

Radiomics-based fertility-sparing treatment in endometrial carcinoma: a review

In recent years, with the increasing incidence of endometrial carcinoma in women of child-bearing age, to decision of whether to preserve patients’ fertility during treatment has become increasingly complex, presenting a formidable challenge for both physicians and patients. Non-fertility-sparing tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuanjian, Chen, Zhongshao, Liu, Chang, Chu, Ran, Li, Xiao, Li, Mingbao, Yu, Dexin, Qiao, Xu, Kong, Beihua, Song, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2023
Materias:	Critical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356732/ https://www.ncbi.nlm.nih.gov/pubmed/37466860 http://dx.doi.org/10.1186/s13244-023-01473-y

Ejemplares similares

Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia
por: Zhang, Qing, et al.
Publicado: (2017)

Fertility-sparing treatment for patients with endometrial carcinoma
por: Ind, T
Publicado: (2023)

Fertility-sparing treatment in women with endometrial cancer
por: Won, Seyeon, et al.
Publicado: (2020)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma(,)
por: Rodolakis, Alexandros, et al.
Publicado: (2023)

ESGO/ESHRE/ESGE Guidelines for the fertility-sparing treatment of patients with endometrial carcinoma
por: Rodolakis, A, et al.
Publicado: (2023)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
por: Chen, Junyu, et al.
Publicado: (2022)

Oncologic and obstetrical outcomes with fertility-sparing treatment of cervical cancer: a systematic review and meta-analysis
por: Zhang, Qing, et al.
Publicado: (2017)

Fertility-sparing treatment of endometrial cancer: options, outcomes and pitfalls
por: Kesterson, Joshua P., et al.
Publicado: (2012)

Breast cancer in the setting of fertility-sparing treatment for endometrial cancer
por: Moss, Haley A., et al.
Publicado: (2014)

Pushing the envelope: expanding fertility sparing treatment of endometrial cancer
por: Stewart, Katherine Ikard, et al.
Publicado: (2020)

Hysteroscopic Curettage Followed by Megestrol Acetate Plus Metformin as a Fertility-Sparing Treatment for Women with Atypical Endometrial Hyperplasia or Well-Differentiated Endometrioid Endometrial Carcinoma
por: Jing, Chu-Yu, et al.
Publicado: (2022)

Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
por: Ding, Yingqiao, et al.
Publicado: (2022)

Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study
por: Chu, Ran, et al.
Publicado: (2022)

Fertility-sparing surgery for patients with low-grade endometrial stromal sarcoma
por: Xie, Weimin, et al.
Publicado: (2016)

Fertility-Sparing Treatment of Patients with Endometrial Cancer: A Review of the Literature
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2021)

Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes
por: Mutlu, Levent, et al.
Publicado: (2022)

Fertility-Sparing Treatment and Assisted Reproductive Technology in Patients with Endometrial Carcinoma and Endometrial Hyperplasia: Pregnancy Outcomes after Embryo Transfer
por: Friedlander, Hilary, et al.
Publicado: (2023)

Fertility-Sparing Approach in Women Affected by Stage I and Low-Grade Endometrial Carcinoma: An Updated Overview
por: Gullo, Giuseppe, et al.
Publicado: (2021)

Use of clinicopathological factors to predict prognosis of fertility-sparing treatment for endometrial endometrioid carcinoma and atypical hyperplasia
por: Zhang, Xiaobo, et al.
Publicado: (2022)

Management of Recurrent Endometrial Cancer or Atypical Endometrial Hyperplasia Patients After Primary Fertility-Sparing Therapy
por: Chen, Junyu, et al.
Publicado: (2021)

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
por: Contreras, Nayanar-Adela, et al.
Publicado: (2022)

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy
por: Ga, Hiromi, et al.
Publicado: (2023)

HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer
por: Dou, Zhiyuan, et al.
Publicado: (2022)

Fertility Sparing Treatment in Young Patients with Early Endometrial Adenocarcinoma: Case Series
por: Jafari Shobeiri, Mehri, et al.
Publicado: (2013)

Dual progestin therapy for fertility-sparing treatment of grade 2 endometrial adenocarcinoma
por: Newtson, A.M., et al.
Publicado: (2017)

Fertility-sparing treatment in early endometrial cancer: current state and future strategies
por: Obermair, Andreas, et al.
Publicado: (2020)

Fertility-Sparing Methods in Adolescents Affected by Endometrial Cancer: A Comprehensive Review
por: Gałczyński, Krzysztof, et al.
Publicado: (2021)

Effect of bariatric surgery on endometrial cancer regression as part of fertility sparing treatment
por: Lin, Jinlin, et al.
Publicado: (2023)

Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
por: Fan, Yuan, et al.
Publicado: (2021)

Hysteroscopy in fertility-sparing management for early endometrial cancer: a double-edged sword
por: Park, Jeong-Yeol
Publicado: (2017)

Fertility sparing treatment for early stage endometrial cancer: current situation and new strategy
por: Ushijima, Kimio
Publicado: (2019)

Fertility Sparing Treatments in Endometrial Cancer Patients: The Potential Role of the New Molecular Classification
por: Cavaliere, Anna Franca, et al.
Publicado: (2021)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Safety of Fertility-Sparing Surgery in Primary Mucinous Carcinoma of the Ovary
por: Lee, Jung-Yun, et al.
Publicado: (2015)

Fertility Sparing Treatment in Gastric-Type Endocervical Carcinoma
por: Rychlik, Agnieszka, et al.
Publicado: (2021)

Fertility-Sparing Surgery in Infiltrative Mucinous Carcinoma of the Ovary
por: ben Ltaief, Sarra, et al.
Publicado: (2023)

Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
por: Yang, Bingyi, et al.
Publicado: (2018)

Fertility-Sparing Treatment in Young Women with Atypical Endometrial Hyperplasia and Low-Grade Endometrial Cancer: A Tertiary Center Experience
por: Shikeli, Sumaya, et al.
Publicado: (2020)

Long-term outcomes of progestin plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer patients
por: Mitsuhashi, Akira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g6outjur2vcgrced26qd11dv06